{
    "clinical_study": {
        "@rank": "109353", 
        "acronym": "OPAL BALANCE", 
        "arm_group": {
            "arm_group_label": "Tofacitinib", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "This is a Phase 3, long-term open-label extension study to evaluate the safety, tolerability\n      and efficacy of tofacitinib in subjects with active PsA who have previously participated in\n      randomized studies of tofacitinib for this indication."
        }, 
        "brief_title": "Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis", 
        "completion_date": {
            "#text": "January 2019", 
            "@type": "Anticipated"
        }, 
        "condition": "Arthritis, Psoriatic", 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Psoriatic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Previous participation in qualifying PsA study involving tofacitinib\n\n        Exclusion Criteria:\n\n          -  Time from End of Study visit of qualifying study is >3 months.\n\n          -  Pregnant female, breastfeeding female or female of childbearing potential unwilling\n             or unable to use highly effective birth control for duration of study and one\n             ovulatory cycle thereafter."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "700", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01976364", 
            "org_study_id": "A3921092"
        }, 
        "intervention": [
            {
                "arm_group_label": "Tofacitinib", 
                "description": "Tofacitinib 5 mg tablet twice daily", 
                "intervention_name": "Tofacitinib", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Tofacitinib", 
                "description": "Tofactinib 10 mg tablet twice daily", 
                "intervention_name": "Tofacitinib", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Tofacitinib", 
            "Psoriatic Arthritis", 
            "Xeljanz", 
            "CP-690550", 
            "Jak-inhibitor", 
            "oral treatment", 
            "psoriasis", 
            "OPAL BALANCE", 
            "moderate", 
            "sever", 
            "pruritus", 
            "itch", 
            "DLQI"
        ], 
        "lastchanged_date": "May 9, 2014", 
        "link": {
            "description": "To obtain contact information for a study center near you, click here.", 
            "url": "https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A3921092&StudyName=Open-Label%20Extension%20Study%20Of%20Tofacitinib%20In%20Psoriatic%20Arthritis"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Huntsville", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35801"
                    }, 
                    "name": "Rheumatology Associates of North Alabama, PC"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Palm Desert", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92260"
                    }, 
                    "name": "Desert Medical Advances"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rancho Mirage", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92270"
                    }, 
                    "name": "Advances In Medicine"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92108"
                    }, 
                    "name": "San Diego Arthritis Medical Clinic"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Trumbull", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06611"
                    }, 
                    "name": "New England Research Associates, LLC"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orlando", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32806"
                    }, 
                    "name": "Rheumatology Associates of Central Florida, PA"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Palm Harbor", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "34684"
                    }, 
                    "name": "Arthritis Center, Inc."
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lexington", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40504"
                    }, 
                    "name": "Bluegrass Community Research, Inc."
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hagerstown", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21740"
                    }, 
                    "name": "Klein and Associates, M.D., P.A."
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Battle Creek", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "49015"
                    }, 
                    "name": "Bronson Internal Medicine and Rheumatology"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lincoln", 
                        "country": "United States", 
                        "state": "Nebraska", 
                        "zip": "68516"
                    }, 
                    "name": "Physician Research Collaboration, LLC"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lebanon", 
                        "country": "United States", 
                        "state": "New Hampshire", 
                        "zip": "03756"
                    }, 
                    "name": "Dartmouth-Hitchcock Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Duncansville", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "16635"
                    }, 
                    "name": "Altoona Center for Clinical Research"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wyomissing", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19610"
                    }, 
                    "name": "Clinical Research Center of Reading, LLP"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jackson", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "38305"
                    }, 
                    "name": "Arthritis Clinic"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jackson", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "38305"
                    }, 
                    "name": "West Tennessee Research Institute"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77008"
                    }, 
                    "name": "Pioneer Research Solutions,Inc."
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Middleton", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "53562"
                    }, 
                    "name": "PharmaSeek, LLC"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Elblag", 
                        "country": "Poland", 
                        "zip": "82-300"
                    }, 
                    "name": "\"Centrum Kliniczno- Badawcze J.J Brzezicki"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lublin", 
                        "country": "Poland", 
                        "zip": "20-582"
                    }, 
                    "name": "Zespol Poradni Specjalistycznych Reumed Filia Onyksowa"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mazowieckie", 
                        "country": "Poland", 
                        "zip": "01-868"
                    }, 
                    "name": "Medica Pro Familia Sp. z o.o. Spolka Komandytowo Akcyjna"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nadarzyn", 
                        "country": "Poland", 
                        "zip": "05-830"
                    }, 
                    "name": "NZOZ Lecznica MAK-MED s.c."
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Warszawa", 
                        "country": "Poland", 
                        "zip": "02-758"
                    }, 
                    "name": "Klinika Ambroziak Estederm Sp. z o.o. S.K.A."
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Warszawa", 
                        "country": "Poland", 
                        "zip": "01-868"
                    }, 
                    "name": "Medica Pro Familia Sp. z o.o. S.K.A."
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Poland"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "A Long-Term, Open-Label Extension Study Of Tofacitinib (CP-690,550) For The Treatment Of Psoriatic Arthritis", 
        "overall_contact": {
            "last_name": "Pfizer CT.gov Call Center", 
            "phone": "1-800-718-1021"
        }, 
        "overall_official": {
            "affiliation": "Pfizer", 
            "last_name": "Pfizer CT.gov Call Center", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "January 2019", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Counts of participants who had treatment-emergent adverse events (TEAEs), defined as newly occurring or worsening after first dose. Relatedness to [study drug] was assessed by the investigator (Yes/No). Participants with multiple occurrences of an AE within a category were counted once within the category.", 
                "measure": "Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline up to Month 36"
            }, 
            {
                "description": "Pre-defined criteria were established for each laboratory test to define the values that would be identified as of potential clinical importance.", 
                "measure": "Number of Participants With Laboratory Test Values of Potential Clinical Importance", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline up to Month 36"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01976364"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "ACR20 response: greater than or equal to (\u2265) 20 percent (%) improvement in tender joint count; \u2265 20% improvement in swollen joint count; and \u2265 20% improvement in at least 3 of 5 remaining ACR core measures: participant assessment of pain; participant global assessment of disease activity; physician global assessment of disease activity; self-assessed disability (disability index of the Health Assessment Questionnaire [HAQ]); and C-Reactive Protein (CRP).", 
                "measure": "Number of Participants With an American College of Rheumatology 20% (ACR20) Response", 
                "safety_issue": "No", 
                "time_frame": "Month 1, Month 3, Month 6, Month 9, Month 12, Month 15, Month 18, Month 21. Month 24, Month 27, Month 30, Month 33, Month 36"
            }, 
            {
                "description": "ACR50 response: greater than or equal to (\u2265) 50 percent (%) improvement in tender or swollen joint counts and 50% improvement in 3 of the following 5 criteria: 1) physician's global assessment of disease activity, 2) subject's assessment of disease activity, 3) subject's assessment of pain, 4) subject's assessment of functional disability via a health assessment questionnaire, and 5) C-reactive protein at each visit.", 
                "measure": "Number of Participants Achieving American College of Rheumatology 50% (ACR50) Response", 
                "safety_issue": "No", 
                "time_frame": "Month 1, Month 3, Month 6, Month 9, Month 12, Month 15, Month 18, Month 21, Month 24, Month 27, Month 30, Month 33, Month 36"
            }, 
            {
                "description": "ACR70 response: greater than or equal to (\u2265) 70 percent (%) improvement in tender or swollen joint counts and 70% improvement in 3 of the following 5 criteria: 1) physician's global assessment of disease activity, 2) subject's assessment of disease activity, 3) subject's assessment of pain, 4) subject's assessment of functional disability via a health assessment questionnaire, and 5) C-reactive protein at each visit.", 
                "measure": "Number of Participants Achieving American College of Rheumatology 70% (ACR70) Response", 
                "safety_issue": "No", 
                "time_frame": "Month 1, Month 3, Month 6, Month 9, Month 12, Month 15, Month 18, Month 21. Month 24, Month 27, Month 30, Month 33, Month 36"
            }, 
            {
                "description": "Score on Health Assessment Questionnaire-Disability Index patient reported outcome", 
                "measure": "Score on Health Assessment Questionnaire- Disability Index", 
                "safety_issue": "No", 
                "time_frame": "Month 1, Month 3, Month 6, Month 9, Month 12, Month 15, Month 18, Month 21, Month 24, Month 27, Month 30, Month 33. Month 36"
            }, 
            {
                "description": "PsARC is comprised of 4 clinical improvement criteria: 1 unit improvement on Physician Global Assessment: 20% (0-100 scale) improvement on the participant assessments; and 30% reduction in number of tender joints; and 30% reduction in the number of swollen joints.  To achieve a clinical response, the participant must improve in 2 of the 4 PsARC criteria, 1 of which has to be the number of tender or swollen joints and none of the 4 scores could worsen", 
                "measure": "Number of participants achieving Psoriatic Arthritis Response Criteria (PsARC)", 
                "safety_issue": "No", 
                "time_frame": "Month 1, Month 3, Month 6. Month 9, Month 12, Month 15, Month 18, Month 21, Month 24, Month 27, Month 30, Month 33, Month 36"
            }, 
            {
                "description": "PGA Psoriasis scale ranges from 0 (no psoriasis) to 5 (severe disease).", 
                "measure": "Physician's Global Assessment of Psoriasis score", 
                "safety_issue": "No", 
                "time_frame": "Month 1, Month 3, Month 6, Month 9, Month 12, Month 15, Month 18, Month 21. Month 24, Month 27, Month 30, Month 33, Month 36"
            }, 
            {
                "description": "Proportion of subjects achieving at least a 75% reduction in PASI relative to baseline and PASI component scores", 
                "measure": "Psoriasis Area and Severity Index 75 (PASI)", 
                "safety_issue": "No", 
                "time_frame": "Month 1, Month 3, Month 6, Month 9, Month 12, Month 15, Month 18, Month 21, Month 24, Month 27, Month 30, Month 33, Month 36"
            }, 
            {
                "description": "Dactylitis score is based upon digit tenderness for each digit of hands and feet ranges from 0-60.", 
                "measure": "Dactylitis severity score", 
                "safety_issue": "No", 
                "time_frame": "Month 1, Month 3, Month 6, Month 9, Month 12, Month 15, Month 18, Month 21, Month 24, Month 27, Month 30, Month 33, Month 36"
            }, 
            {
                "description": "Enthesitis score is based upon presence/absence of enthesitis at 16 sites (SPARCC) or 6 sites (Leeds)", 
                "measure": "Enthesitis score based upon SPARCC (Spondylitis Research Consortium) and Leeds indices", 
                "safety_issue": "No", 
                "time_frame": "Month 1, Month 3, Month 6, Month 9, Month 12, Month 15, Month 18, Month 21, Month 24, Month 27, Month 30, Month 33, Month 36"
            }, 
            {
                "description": "BASDAI is a validated self-assessment tool used to determine disease activity in participant with Ankylosing Spondylitis (AS) utilizing a visual analogue scale of 0-10 (0=none and 10=very severe).  Answers to six questions measuring are averaged for a final score ranging from 0-10.", 
                "measure": "Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)", 
                "safety_issue": "No", 
                "time_frame": "Month 1, Month 3, Month 6, Month 9, Month 12, Month 15, Month 18, Month 21, Month 24, Month 27, Month 30, Month 33, Month 36"
            }, 
            {
                "description": "SF-36 is a standardized survey evaluating 8 aspects of functional health and well-being.  The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning).", 
                "measure": "36-Item Short-Form Health Survey (SF-36)", 
                "safety_issue": "No", 
                "time_frame": "Month 1, Month 6, Month 12, Month 18, Month 24, Month 30, Month 36"
            }, 
            {
                "description": "EQ5D is a participant rated questionnaire to assess health-related quality of life in terms of a single utility score.  Health State Profile component assesses level of current health for 5 domains; 1 indicates better health state (no problems) and 3 indicates worst health state.", 
                "measure": "Euro Quality of Life (EQ-5D)- Health State Profile Utility Score (EQ-5D)", 
                "safety_issue": "No", 
                "time_frame": "Month 1, Month 6, Month 12, Month 18, Month 24, Month 30, Month 36"
            }, 
            {
                "description": "FACIT-F is a participant rated questionnaire to assess fatigue", 
                "measure": "Functional Assessment of Chronic Illness Therapy- Fatigue (FACIT-F)", 
                "safety_issue": "No", 
                "time_frame": "Month 1, Month 6, Month 12, Month 18, Month 24, Month 30, Month 36"
            }
        ], 
        "source": "Pfizer", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pfizer", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}